Corticotropin-releasing hormone receptor

From WikiMD's WELLNESSPEDIA

Corticotropin-releasing hormone receptor (CRHR) is a type of G protein-coupled receptor that binds corticotropin-releasing hormone (CRH). CRH is a peptide hormone and neurotransmitter involved in the stress response.

Structure[edit]

CRHR is a member of the secretin family of G protein-coupled receptors. It is a transmembrane protein that is activated by CRH and urocortin, a related peptide hormone. The receptor has two main subtypes, CRHR1 and CRHR2, which differ in their distribution throughout the body and their affinity for CRH and urocortin.

Function[edit]

CRHR plays a crucial role in the body's response to stress. When activated by CRH or urocortin, it stimulates the release of adrenocorticotropic hormone (ACTH) from the pituitary gland. ACTH then stimulates the adrenal glands to produce and release cortisol, a hormone that helps the body respond to stress.

In addition to its role in the stress response, CRHR is also involved in other physiological processes, including inflammation, immune response, and behavior.

Clinical significance[edit]

Alterations in the CRHR system have been implicated in a number of psychiatric disorders, including depression, anxiety disorders, and post-traumatic stress disorder (PTSD). Some evidence suggests that CRHR1 antagonists may have therapeutic potential in the treatment of these disorders.

See also[edit]


This GPCR-related article is a stub. You can help WikiMD by expanding it.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.